News from the FDA/CDC

Flu activity falling but still elevated


 

Measures of influenza activity fell again as the flu season continues to make its later-than-usual departure this year, according to the Centers for Disease Control and Prevention.

Influenza-like illness activity level, week ending March 30, 2019

On the geographic front, the map of influenza-like illness (ILI) activity for the week ending March 30 shows that only 6 states are at level 10 on the CDC’s 1-10 scale, compared with 11 for the previous week, and that those same 6 states make up the entire membership of the high range of levels 8-10, which is down from 20 states a week ago, data from the CDC’s Outpatient ILI Surveillance Network show.

The proportion of outpatient visits for ILI, now at 3.2%, dropped for the sixth consecutive week after reaching its season high of 5.1% back in mid-February. The outpatient rate has now been at or above the national baseline of 2.2% for 19 weeks this season, the CDC’s influenza division said April 5, noting that the average for the past five seasons is 16 weeks.

Six flu-related pediatric deaths were reported in the week ending March 30, and the total is now 82 for the 2018-2019 season. Five of the six occurred during previous weeks of this season, and one occurred in the 2017-2018 season, the CDC said.

Recommended Reading

Flu season showing its staying power
MDedge Infectious Disease
Influenza activity continues to increase
MDedge Infectious Disease
New BinaxNOW influenza test gets CLIA waiver
MDedge Infectious Disease
Flu season shows signs of peaking
MDedge Infectious Disease
Flu activity down for a second straight week
MDedge Infectious Disease
Flu activity levels down, but outpatient visits highest since 1998-99
MDedge Infectious Disease
H3N2 putting a damper on flu season’s departure
MDedge Infectious Disease
2018-2019 flu season: Going but not gone yet
MDedge Infectious Disease
Flu shot can be given irrespective of the time of last methotrexate dose
MDedge Infectious Disease
NIH to undertake first in-human trial of universal influenza vaccine
MDedge Infectious Disease